Ascend Capital’s Stericycle Inc SRCL Stock Holding History

Ascend Capital’s Portfolio SRCL Stock Details SRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-198,687	Closed	-$14.2M	–	256
2017 Q3	$14.2M	Buy	+198,687	New	+$14.6M	0.54%	62

Other funds holding SRCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ascend Capital's SRCL Position: Q4 2017 in Review

Ascend Capital sold out of Stericycle Inc (SRCL) in Q4 2017, closing a stake of 198,687 shares — an estimated $14.2M sold.

Ascend Capital first reported a position in SRCL in Q3 2017 and held it in 1 quarter. The position peaked at $14.2M in Q3 2017. 520 funds tracked by Wall St. Rank hold SRCL as of Q4 2017.

Ascend Capital reported no remaining Stericycle Inc position as of Q4 2017 after selling out during the quarter.
Ascend Capital sold 198,687 Stericycle Inc shares in Q4 2017, an estimated $14.2M.
Ascend Capital first reported a position in Stericycle Inc in Q3 2017 and held it in 1 quarter.
Ascend Capital's Stericycle Inc position peaked at $14.2M in Q3 2017.
520 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2017.

Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.